共 25 条
[1]
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
[J].
ARTHRITIS AND RHEUMATISM,
2008, 58 (05)
:1299-1309
[2]
Conaghan P, 2010, ARTHRITIS RHEUM, V62, pS759
[6]
An Oral Syk Kinase Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized, Placebo-Controlled, Phase II Study in Patients With Active Rheumatoid Arthritis That Did Not Respond to Biologic Agents
[J].
ARTHRITIS AND RHEUMATISM,
2011, 63 (02)
:337-345
[7]
Genovese MC, 2008, ARTHRITIS RHEUM, V58, pS369
[10]
Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
[J].
ARTHRITIS AND RHEUMATISM,
2011, 63 (03)
:609-621